Rushikesh Shah, MD
Gastroenterology · Dallas, TXNPI 1144578378
Payments from drug & device makers
Across 422 payments — averaging $83.24 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$17K
- W. L. Gore & Associates, Inc.$10K
- Boston Scientific$2K
- Conmed Corporation$1K
- Endogastric Solutions, Inc$890
- Takeda Pharmaceuticals U.S.A., Inc.$700
- plus $3K from 25 others
What the payments were for
- Consulting fees$9,01026%
- Speaking & faculty fees$11,87534%
- Travel & lodging$3,0249%
- Food & beverage$11,04031%
- Education$1791%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 205 | $17,176 |
| W. L. Gore & Associates, Inc. | 8 | $10,193 |
| Boston Scientific | 48 | $2,462 |
| Conmed Corporation | 13 | $1,146 |
| Endogastric Solutions, Inc | 6 | $890 |
| Takeda Pharmaceuticals U.S.A., Inc. | 38 | $700 |
| Johnson & Johnson | 18 | $397 |
| Cook Medical LLC | 7 | $308 |
| Sanofi | 8 | $220 |
| 3-d Matrix, Inc. | 1 | $156 |
| Ferring Pharmaceuticals Inc. | 7 | $156 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $155 |
| ERBE USA Inc | 1 | $100 |
| Aimmune Therapeutics, Inc. | 5 | $96 |
| Nestle Healthcare Nutrition Inc. | 6 | $96 |
| Merck | 5 | $90 |
| Intercept Pharmaceuticals, Inc. | 4 | $89 |
| Fujifilm Healthcare Americas Corporation | 1 | $85 |
| Redhill Biopharma Inc. | 4 | $79 |
| Braintree Laboratories, Inc. | 4 | $72 |
| Vivus LLC | 4 | $69 |
| Regeneron Healthcare Solutions, Inc. | 3 | $69 |
| Micro-tech Endoscopy USA, Inc. | 1 | $67 |
| QOL Medical, LLC | 4 | $66 |
| Ardelyx, Inc. | 3 | $60 |
| Pfizer | 3 | $58 |
| Madrigal Pharmaceuticals | 1 | $22 |
| Phathom Pharmaceuticals, Inc. | 1 | $20 |
| Ironwood Pharmaceuticals, Inc | 1 | $19 |
| Olympus America Inc. | 1 | $12 |
| Gastrogpo, LLC | 3 | $0 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GORE VIABIL Biliary Endoprosthesis$10,193
- Creon$8,489
- ESOPHYX$770
- CONMED BILIARY$702
- Resolution 360 Clip$406
- EXALT$261
- EXALT Model D$215
- CONMED DILATION$165
- SYSTEM 2450$147
- CONMED GASTROSTOMY$131
- CONMED GENERATORS$131
- AXIOS$124
- Instinct$124
- SPYGLASS$119
- LINZESS$116
- ECHOTIP INSIGHT$116
- Mavyret$106
- GENERAL - THERAPIES$105
- VIO3$100
How this compares
$35,127 in reported general payments places this provider in the 85th percentile of 1,350 gastroenterology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| CreonLipase/Protease/Amylase | 30 | $76,530 |
| ZenpepLipase/Protease/Amylase | 11 | $57,945 |
| LinzessLinaclotide | 19 | $14,440 |
| Sucralfate | 13 | $1,964 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 69 | $1,583 |
| Scopolamine | 17 | $1,354 |
| Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates | 20 | $1,158 |
| Pantoprazole Sodium | 41 | $1,063 |
| Omeprazole | 77 | $742 |
| CholestyramineCholestyramine (With Sugar) | 15 | $596 |
| Ondansetron OdtOndansetron | 19 | $417 |
| Gabapentin | 42 | $345 |
| Dicyclomine Hcl | 13 | $195 |
| Metoclopramide Hcl | 12 | $107 |
| Famotidine | 13 | $78 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieCreon, Linzess | $17,176 | $90,97149 claims |
| Aimmune Therapeutics, Inc.Zenpep | $96 | $57,94511 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,350 gastroenterology providers in Texas.
Other gastroenterology in Dallas
- John FordtranDallas$9.9M
- Parvez MantryDallas$6.4M
- Michael BrownDallas$5.5M
- Jacqueline O LearyDallas$1.4M
- Themistocles DassopoulosDallas$1.1M
- Moheb BoktorDallas$1M
- Lisa VanwagnerDallas$486K
- Rodney InfanteDallas$442K
- Eric LawitzSan Antonio$59.5M
- George DuvallTyler$17.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.